Hybrid Nanogel Drug Delivery Systems: Transforming the Tumor Microenvironment through Tumor Tissue Editing
Cells · 2024
DOI: 10.3390/cells13110908 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2024. Verfasst von Theodora Katopodi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Biology and Genetics, Department of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece. Hauptthemen laut MEDLINE: Tumor Microenvironment, Drug Delivery Systems, Nanogels, Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, European network grant and the Greek General Secretariat for Research and Innovation (GSRT).
Abstract (Originalsprache)
The future of drug delivery offers immense potential for the creation of nanoplatforms based on nanogels. Nanogels present a significant possibility for pharmaceutical advancements because of their excellent stability and effective drug-loading capability for both hydrophobic and hydrophilic agents. As multifunctional systems, composite nanogels demonstrate the capacity to carry genes, drugs, and diagnostic agents while offering a perfect platform for theranostic multimodal applications. Nanogels can achieve diverse responsiveness and enable the stimuli-responsive release of chemo-/immunotherapy drugs and thus reprogramming cells within the TME in order to inhibit tumor proliferation, progression, and metastasis. In order to achieve active targeting and boost drug accumulation at target sites, particular ligands can be added to nanogels to improve the therapeutic outcomes and enhance the precision of cancer therapy. Modern “immune-specific” nanogels also have extra sophisticated tumor tissue-editing properties. Consequently, the introduction of a multifunctional nanogel-based drug delivery system improves the targeted distribution of immunotherapy drugs and combinational therapeutic treatments, thereby increasing the effectiveness of tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Medical Biology and Genetics, Department of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
- Department of Pulmonology, I.M. Sechenov First Moscow State Medical University, Moscow 119992, Russia.
- Department of Electrical and Computer Engineering, University of Thessaly, 38334 Volos, Greece.
- Pulmonary Department-Oncology Unit, G. Papanikolaou General Hospital, Aristotle University of Thessaloniki, 57010 Thessaloniki, Greece.
- Third Department of Surgery, AHEPA University Hospital, Aristotle University of Thessaloniki, 55236 Thessaloniki, Greece.
ORCID-Profile: Savvas Petanidis, George Floros
Förderung
- European Union
- European network grant and the Greek General Secretariat for Research and Innovation (GSRT)
Zitieren
APA
Katopodi, T., Petanidis, S., Floros, G., Porpodis, K., & Kosmidis, C. (2024). Hybrid Nanogel Drug Delivery Systems: Transforming the Tumor Microenvironment through Tumor Tissue Editing. Cells. https://doi.org/10.3390/cells13110908
Vancouver
Katopodi T, Petanidis S, Floros G, Porpodis K, Kosmidis C. Hybrid Nanogel Drug Delivery Systems: Transforming the Tumor Microenvironment through Tumor Tissue Editing. Cells. 2024. doi:10.3390/cells13110908
BibTeX
@article{Katopodi2024,
author = {Katopodi, Theodora and Petanidis, Savvas and Floros, George and Porpodis, Konstantinos and Kosmidis, Christoforos},
title = {Hybrid Nanogel Drug Delivery Systems: Transforming the Tumor Microenvironment through Tumor Tissue Editing},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13110908}
}
EUVIMED